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Abstract A 24-h incubation with hydrogen peroxide (0.65 mM) 
markedly reduced viability of cultured endothelial cells. Pre-
incubation with aspirin (3-30 uM) protected endothelial cells 
from hydrogen peroxide-induced toxicity and increased viability 
in a concentration-dependent fashion by up to 64% of control. A 
similar protection was observed with D-a-tocopherol acetate 
(vitamin E, 3-30 \iM). The cytoprotective effects of aspirin and 
vitamin E against hydrogen peroxide were overadditive suggest-
ing different mechanisms of antioxidant action. In agreement 
with this, cytotoxicity induced by iron, the main catalyst of 
oxygen radical formation, was substantially reduced by aspirin 
but not vitamin E. These results show that aspirin protects 
endothelial cells from oxidative stress possibly via binding or 
chelation of free cytosolic iron. Moreover, a combination of 
aspirin and vitamin E might be useful for the prevention of 
endothelial injury in cardiovascular disease, e.g. during ather-
ogenesis. 
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1. Introduction 
Aspirin is widely used in the secondary prevention of 
thrombotic occlusive events such as myocardial infarction 
and stroke [1]. There is general agreement that the underlying 
mechanism of action is through irreversible inhibition of 
platelet cyclooxygenase activity and thromboxane formation, 
the latter being a potent agonist of vascular smooth muscle 
contraction and the aggregation of platelets [2,3]. While in-
creased platelet activity in fact plays a crucial role during 
acute thrombus formation, it is the reduced integrity of the 
endothelial cell lining, i.e. endothelial damage, that facilitates 
adhesion of platelets and other blood cells to the vascular wall 
and can thus be considered a primary cause of atherogenesis 
and thrombosis [4]. Moreover, the intact endothelial layer 
serves as a selective barrier for plasma lipids and also has 
anti thrombotic properties [4]. In addition to platelet inhibi-
tion, protection and preservation of the vascular endothelium 
may therefore be an important and equally effective approach 
to interfere with the initiating events of atherosclerosis and to 
prevent occlusive cardio- and cerebrovascular diseases. 
Compelling evidence suggests that oxidative stress is a car-
diovascular risk factor and contributes significantly to endo-
thelial damage during atherogenesis. Besides oxidation of low-
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density lipoprotein, oxygen-centered radicals are capable of 
directly injuring the endothelium, e.g. when released by at-
tached neutrophils or monocytes [5,6]. In this study we used 
an established in vitro model of free radical injury in the 
vasculature by exposing cultured endothelial cells to oxidative 
stress induced by incubation with hydrogen peroxide [7,8]. 
Our aim was to determine if, in addition to its well-known 
platelet inhibitory action, aspirin has a direct endothelial pro-
tective effect, i.e. is capable of increasing endothelial resistance 
towards oxidative damage. The cytoprotective effects of aspir-
in are compared to those of D-a-tocopherol acetate (vitamin 
E), an established antioxidant and radical scavenger. 
2. Materials and methods 
2.1. Materials 
Bovine pulmonary artery endothelial cells (ATCC CCL 209) were 
obtained from the American Type Culture Collection, Rockville, MD, 
USA. Fetal bovine serum, Dulbecco's modified Eagle medium and 
penicillin-streptomycin were obtained from Gibco, Eggenstein, Ger-
many. Hydrogen peroxide, ammonium iron(II) sulfate, and 8-hydrox-
yquinoline were from Merck, Darmstadt, Germany. Vitamin E (D-a-
tocopherol acetate), aspirin and all other chemicals were purchased 
from Sigma, Deisenhofen, Germany. 
2.2. Cell culture 
Endothelial cells were maintained and subcultured in Dulbecco's 
modified Eagle medium supplemented with 15% fetal bovine serum, 
100 U/ml penicillin and 100 ug/ml streptomycin [9]. The cells were 
grown in a humidified incubator at 37°C, 5% C0 2 and 95% air. 
2.3. Incubation procedure 
Endothelial cells were seeded at 2X104 cells/well in 96-well micro-
titer plates in 100 ul of medium containing 15%i fetal bovine serum. 
Upon reaching confluence cells were preincubated for 8 h with aspirin 
or/and vitamin E. After the preincubation period, hydrogen peroxide 
or a freshly prepared mixture of ammonium iron(II) sulfate (50 uM) 
and 8-hydroxyquinoline (50 uM), the latter serving as iron transporter 
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Fig. 1. Effect of aspirin on H202-induced cytotoxicity in endothelial 
cells. Incubations were carried out as described in Section 2. 
*P<0.05, aspirin vs. control (CON), two-tailed (-test. All data 
shown are mean ± S.E.M. of n = 6 observations. 
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Fig. 2. Effect of vitamin E on H202-induced cytotoxicity in endo-
thelial cells. Incubations were carried out as described in Section 2. 
*P<0.05, vitamin E vs. control (CON), two-tailed Mest. All data 
shown are mean ± S.E.M. of n = 6 observations. 
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Fig. 4. Effect of aspirin and vitamin E on endothelial toxicity in-
duced by ammonium iron(II) sulfate (Fe(NH4)2(S04)2/8-hydroxyqui-
noline). Incubations were carried out as described in Section 2. 
*P<0.05, treatment vs. control (CON), two-tailed Mest. All data 
shown are mean ± S.E.M. of n - 6 observations. 
across cell membranes [6], was added to the cells. Incubation was 
continued for 24 h, followed by a cytotoxicity assay. 
2.4. Cytotoxicity assay 
Cell viability was measured by staining with crystal violet as pre-
viously described [9-11]. This colorimetric test allows the assessment 
of the remaining viable cells and therefore does not discriminate be-
tween necrotic and apoptotic events. After washing with phosphate 
buffered saline, cells were fixed with methanol for 5 min and then 
stained for 10 min with a 0.1% crystal violet solution. Following three 
washes with tap water, the dye was eluted with 0.1 mol/1 trisodium 
citrate in 50% ethanol for 1 h. Optical density at 630 nm was meas-
ured using a microtiter plate reader (Biotek EL 311s). 
3. Results 
In endothelial cells, treatment with hydrogen peroxide (650 
uM) markedly reduced the number of viable cells (Fig. 1). 
Preincubation with aspirin (10-30 uM) protected endothelial 
cells from hydrogen peroxide-mediated cytotoxicity in a con-
centration-dependent manner and increased viability by up to 
64% of control (Fig. 1). Vitamin E (3-30 uM) also tended to 
protect endothelial cells from oxidant damage (Fig. 2). How-
ever, a significant increase in the number of surviving cells 
(32% of control) was detected only at 30 |jJVl vitamin E. With-
out preincubation, no significant protection by vitamin E and 
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Fig. 3. Synergistic effect of aspirin and vitamin E on H2O2 -induced 
cytotoxicity in endothelial cells. Incubations were carried out as de-
scribed in Section 2. *P < 0.05, treatment vs. control (CON), two-
tailed Mest. All data shown are mean ± S.E.M. of n = 6 observa-
tions. 
aspirin was detected suggesting that the agents need to pene-
trate (not shown). At subthreshold concentrations (20 |0.M), 
vitamin E had a potentiating effect on endothelial protection 
by aspirin. After co-incubation with vitamin E at non-protec-
tive concentrations (20 (xM), endothelial protection by aspirin 
(10 pM) was increased by 50%> (Fig. 3). When ammonium 
iron(II) sulfate/8-hydroxyquinoline (50 uM) was used as a 
cytotoxic agent [6], vitamin E had no effect on the surviving 
cell fraction (Fig. 4). In contrast, aspirin proved to be more 
potent in endothelial protection under these conditions as 
compared to hydrogen peroxide-mediated toxicity: at 1 (J.M 
and 30 uM aspirin, the surviving fraction of endothelial cells 
was increased by 88% and 290%, respectively. Aspirin, vita-
min E, and 8-hydroxyquinoline alone had no significant effect 
on endothelial cell viability (not shown). 
4. Discussion 
The present study demonstrates protection against hydro-
gen peroxide-mediated endothelial toxicity by aspirin. This 
novel pharmacological action may be of therapeutic relevance 
since it was observed at concentrations that are in the range of 
systemic plasma aspirin levels during antithrombotic dosing 
regimens [12,13]. Our findings suggest that in addition to plate-
let inhibition, aspirin has the capacity to directly protect the 
endothelium from the deleterious influences of oxidative 
stress. The established antioxidant and radical scavenger vita-
min E was also found to reduce cytotoxicity by hydrogen 
peroxide, which is in line with previous investigations 
[14,15]. However, when compared on a molar basis, aspirin 
turned out to be about 10-fold more potent in endothelial 
protection than vitamin E. Interestingly, aspirin has been 
shown to possess antioxidant and radical scavenging proper-
ties [16,17] which may explain the aspirin-induced endothelial 
protection against oxidative injury. Our findings are neverthe-
less surprising since aspirin-dependent effects on surface cells 
such as in gastric mucosa have been characterized as irritating 
or cytotoxic rather than protective [18]. Despite widespread 
concern that even under low-dose antithrombotic regimens 
aspirin may lead to suppression of endothelial prostacyclin, 
an antithrombotic and vasodilatory cyclooxygenase metabo-
lite [12,19], according to our data aspirin appears to preserve 
overall endothelial integrity and thereby to actually support 
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the antithrombotic and antiatherogenic function of the endo-
thelium under conditions of oxidative stress. 
At subthreshold concentrations, vitamin E had a potentiat-
ing effect on endothelial protection by aspirin. After co-incu-
bation with vitamin E at non-protective concentrations, endo-
thelial protection by aspirin was substantially increased. This 
overadditive synergism indicates that despite sharing antiox-
idant properties, aspirin and vitamin E may have different 
sites and mechanisms of action. Further support for this as-
sumption is provided by our observation that endothelial tox-
icity induced by the Fenton catalyst iron can be attenuated by 
pretreatment with aspirin but not vitamin E. Free iron (Fe2+) 
is the crucial catalyst of oxygen-centered radical formation in 
biological systems and its removal or intracellular sequestra-
tion results in diminished cellular sensitivity to oxidant dam-
age [5,6,8,20]. Aspirin is known to exhibit metal-binding abil-
ities [16] and may thus withdraw iron ions from the site of 
oxygen radical formation. In agreement with this, we found 
that compared to hydrogen peroxide-mediated cell injury, as-
pirin was 10-fold more potent as a cytoprotective agent when 
toxicity was induced by exogenous ferrous sulfate possibly 
reflecting the high affinity between iron and aspirin. In con-
trast to aspirin, vitamin E acts mainly as a chain-breaking 
radical scavenger in biological membranes [5] which might 
explain the overadditive cytoprotection (potentiation) that oc-
curs when combined with metal-binding aspirin. Of course, 
additional interactions such as facilitated membrane penetra-
tion of aspirin in the presence of vitamin E may also contrib-
ute to the observed synergism. 
Together, our results demonstrate direct endothelial protec-
tion from oxidative damage by aspirin at antithrombotic con-
centrations. Aspirin-induced cytoprotection was markedly in-
creased in the presence of vitamin E. Therefore, a com-
bination of aspirin and vitamin E might be useful for the 
prevention of endothelial injury in cardiovascular disease, 
e.g. during atherogenesis. 
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